The potential of proteomics and peptidomics for allergy and asthma research

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 10, 2005, Pages 1227-1237

  Crameri, Reto ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Allergy; Asthma; Mass spectrometry; Peptidomics; Protein separation; Proteomics

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEOME;

ALLERGY; ASTHMA; BIOINFORMATICS; ELECTROSPRAY MASS SPECTROMETRY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ASTHMA; HYPERSENSITIVITY; PEPTIDES; PROTEOME; PROTEOMICS; RESEARCH;

EID: 24744432068     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00873.x     Document Type: Review

References (126)

1. Venter JC, Adams MD, Myers EW, Smith HO, Miklos GLG, Wides L et al. The sequence of the human genome. Science 2001;291:1304-1351.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
3. Schmutz J, Wheeler J, Grimwood J, Dickson M, Yang J, Caoile C et al. Quality assessment of the human genome sequence. Nature 2004;429:365-368.
4. Hood L, Galas D. The digital code of DNA. Nature 2003;421:444-448.
5. Taylor JG, Choi EH, Foster CB, Chanock SJ. Using genetic variation to study human disease. Trends Mol Med 2001;7:507-512.
6. Rehfeld JF, Goetze JP. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 2003;3:25-38.
7. Huber SC, Hardin SC. Numerous posttranslational modifications provide opportunities for the intricate regulation of metabolic enzymes at multiple levels. Curr Opin Plant Biol 2004;7:318-322.
8. Eisen MB, Spellman PT, Brown PD, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-14868.
9. Lamerz J, Selle H, Scapozza L, Crameri R, Schulz-Knappe P, Mohring T et al. Correlation-associated peptide networks of human cerebrospinal fluid. Proteomics (in press).
10. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003;21:255-261.
11. Standing KG. Peptide and protein de novo sequencing by mass spectrometry. Curr Opin Struct Biol 2003;13:595-601.
12. Chiang DY, Brown PO, Eisen MB. Visualizing associations between genome sequences and gene expression data using genome-mean expression profiles. Bioinformatics 2001;17:S49-S55.
13. Butte AJ, Tamayo P, Slonim D, Golub TR, Kohame JS. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc Natl Acad Sci USA 2000;97:12182-12186.
14. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL. The large scale organization of metabolic networks. Nature 2000;407:651-654.
15. Lamerz J, Crameri R, Scapozza L, Mohring T, Selle H, Zucht HD. Peptide sequence predictions from thousands of peptide signals based on correlation-associated networks. Combin Chem High Throughput Screen 2005 (in press).
16. Roberts GC, Smith CW. Alternative splicing: combinatorial output from the genome. Curr Opin Chem Biol 2002;6:375-383.
17. Jensen ON. Modification-specific proteomics: characterization of posttranslational modifications by mass spectrometry. Curr Opin Chem Biol 2004;8:33-41.
18. Lopez-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 2002;3:509-519.
19. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF et al. Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 1996;13:19-50.
20. Schulz-Knappe P, Zucht HD, Heine G, Jürgens M, Hess R, Schrader M. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Combin Chem High Throughput Screen 2001;4:207-217.
21. Baggerman G, Verleyen P, Clynen E, Huybechts J, de Louf A, Schoofs L. Peptidomics. J Chromatogr B Analyt Technol Biomed Life Sci 2004;803:3-16.
22. Naistat DM, Leblanc R. Proteomics. J Environ Pathol Toxicol Oncol 2004;23:161-178.
23. Domingues FS, Lengauer T. Protein function from sequence and structure data. Appl Bioinform 2003;2:3-12.
24. Meri S, Baumann M. Proteomics: posttranslational modifications, immune responses and current analytical tools. Biomol Eng 2001;18:213-220.
25. Jensen ON. Modification-specific proteomics: characterization of posttranslational modifications by mass spectrometry. Curr Opin Chem Biol 2004;8:33-41.
26. Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L, Ceol A et al. The HUPO PSI's molecular interaction format - a community standard for the representation of protein interaction data. Nat Biotechnol 2004;22:177-183.
27. Cho S, Park SG, Lee du H, Park BC. Protein-protein interaction networks: from interactions to networks. J Biochem Mol Biol 2004;37:45-52.
28. Mann M, Hendrickson RC, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 2001;70:437-473.
29. Domingues FS, Lengauer T. Protein function from sequence and structure data. Appl Bioinform 2003;2:3-12.
30. O'farrel PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-4021.
31. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2002;3:3-10.
32. Fey SL, Larsen PM. 2D or not 2D. Two-dimensional gel electrophoresis. Curr Opin Chem Biol 2001;9:26-33.
33. Joo WA, Lee DY, Kim CW. Development of an effective sample preparation method for the proteome analysis of body fluids using 2-D gel electrophoresis. Biosci Biotechnol Biochem 2003;67:1574-1577.
34. Manabe T. Analysis of complex protein-polypeptide systems for proteomic studies. J Chromatogr B Analyt Technol Biomed Life Sci 2003;787:29-41.
35. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422:198-207.
36. Hoving S, Voshol H, van Oostrum J. Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis 2000;21:2617-2621.
37. Zuo X, Speicher DW. Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two-dimensional electrophoresis. Proteomics 2002;2:58-68.
38. Rose K, Bouguelert L, Baussant T, Bohm G, Botti P, Colinge J et al. Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins. Proteomics 2004;4:2125-2150.
39. Oda Y, Nagasu T, Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol 2001;19:379-382.
40. Wilkins JA, Xiang R, Horvath C. Selective enrichment of low-abundance peptides in complex mixtures by elution-modified displacement chromatography and their identification by electrospray ionization mass spectrometry. Anal Chem 2002;74:3933-3941.
41. Bodnar WM, Blackburn RK, Krise JM, Moseley MA. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J Am Mass Spectrom 2003;14:971-979.
42. Shefcheck K, Yao X, Fenselau C. Fractionation of cytosolic proteins on an immobilized heparin column. Anal Chem 2003;75:1691-1698.
43. Govorukhina NT, Keizer-Gunnink A, van der Zee AG, DE Jong S, de Bruijn HW, Bischoff R. Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion. J Chromatogr A 2003;1009:171-178.
44. Hinerfeld D, Innamorati D, Pirro J, Tam SW. Serum/Plasma depletion with chicken immunoglobulin y antibodies for proteomic analysis from multiple Mammalian species. J Biomol Tech 2004;15:184-190.
45. Quadroni M, James P. Proteomics and automation. Electrophoresis 1999;20:664-677.
46. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000;21:1037-1053.
47. Lin Z, Crockett DK, Lim MS, Elenitoba-Johanson KS. High-throughput analysis of protein/peptide complexes by immunoprecipitation and automated LC-MS/MS. J Biol Technol 2003;14:149-155.
48. Jensen ON, Wilm M, Shevchenko A, Mann M. Peptide sequencing of 2DE gel-isolated proteins by nanoelectrospray tandem mass spectrometry. Methods Mol Biol 1999;112:571-588.
49. Borchers C, Peter JF, Hall MC, Kunkel TA, Tomer KB. Identification of in-gel digested proteins by complementary peptide mass fingerprinting and tandem mass spectrometry data obtained on an electrospray ionization quadruple time-of-flight mass spectrometer. Anal Chem 2000;72:1163-1168.
50. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 2000;97:9390-9395.
51. Colburu WA, Lee JW. Biomarkers, validation and pharmacokinetic- pharmacodynamic modelling. Clin Pharmacokinet 2003;42:997-1022.
52. Kantur AB, Wang W, Lin H, Govindarjan H, Anderle M, Perrone A et al. Biomarker discovery by comprehensive phenotyping for autoimmune diseases. Clin Immunol 2004;111:186-195.
53. Chanin TD, Merrick DT, Franklin WA, Hirsch FR. Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present. Curr Opin Pulm Med 2004;10:242-247.
54. Seliger B, Kellner R. Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics 2002;2:1641-1651.
55. Petricoin E, Wulfkuhle J, Spina V, Liotta LA. Clinical proteomics: Revolutionizing disease detection and patient tailoring therapy. Proteome Res 2004;3:209-217.
56. Oh P, Li Y, Yu J, Burr E, Krasinska KM, Carver LA et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumors for tissue-specific therapy. Nature 2004;429:629-635.
57. Verma M, Kagan J, Sidransky D, Srivastava S. Proteomic analysis of cancer-cell mitochondria. Nat Rev Cancer 2003;3:789-795.
58. Petricoin EF, Liotta LA. Clinical applications of proteomics. J Nutr 2003;133:2476S-2484S.
59. Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 2003;100:605-610.
60. Ramstrom M, Bergquist J. Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry. FEBS Lett 2004;567:92-95.
61. Issaq HJ, Conrads TP, Ianini GM, Veenstra TD. Methods for fractionation, separation and profiling of proteins and peptides. Electrophoresis 2002;23:3048-3061.
62. Stickel JJ, Fotopoules A. Pressure-flow relationships for packed beds of compressible chromatography media at laboratory and production scale. Biotechnol Prog 2001;17:744-751.
63. Schulz-Knappe P, Schrader M, Standker L, Richter R, Hess R, Jürgens M et al. Peptide bank generated by large-scale preparation of circulating human peptides. J Chromatogr A 1997;776:125-132.
64. Skold K, Svensson M, Kaplan A, Bjorkesten L, Astrom J, Andren PE. A neuroproteomic approach to targeting neuropeptides in the brain. Proteomics 2002;2:447-454.
65. Heine G, Zucht HD, Scuhmann MU, Burger K, Jürgens M, Zumkeiler M et al. High-resolution peptide mapping of cerebrospinal fluid: a novel concept for diagnosis and research in central nervous system diseases. J Chromatogr B Analyt Technol Biomed Life Sci 2002;782:353-361.
66. Schrader M, Schulz-Knappe P. Peptidomics technologies for human body fluids. Trends Biotechnol 2001;19(Suppl. 10):S55-S60.
67. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885.
68. Lloyd CM, Rankin SM. Chemokines in allergic airway disease. Curr Opin Pharmacol 2003;3:443-448.
69. Krishnaswamy G, Kelly J, Johnson D, Youngberg G, Stone W, Hung SK et al. The human mast cell: functions in physiology and disease. Front Biosci 2001;6:109-127.
70. Margalit H, Altuvia Y. Insights from MHC-bound peptides. Novartis Found Symp 2003;254:77-90.
71. Purcell AW, German JJ. Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response. Mol Cell Proteomics 2004;3:193-208.
72. Larsen MR, Roepstorff P. Mass spectrometric identification of proteins and characterization of their posttranslational modifications in proteome analysis. Fresenius J Anal Chem 2000;366:677-690.
73. Yates JR III. Mass spectrometry and the age of the proteome. J Mass Spectrom 1998;33:1-19.
74. Fenn JB. Electrospray wings for molecular elephants (Nobel lecture). Angew Chem Int Ed Engl 2003;42:3871-3894.
75. Tanaka K. The origin of macromolecule ionization by laser irradiation (Nobel lecture). Angew Chem Int Ed Engl 2003;42:3860-3870.
76. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
77. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10 000 daltons. Anal Chem 1988;60:2299-2301.
78. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577.
79. Wiemer JC, Prokudin A. Bioinformatics in proteomics: application, terminology, and pitfalls. Pathol Res Pract 2004;200:173-178.
80. Patterson SD. Data analysis - the Achilles heel of proteomics. Nat Biotechnol 2003;21:221-222.
81. Stanislaus R, Jiang LH, Swartz M, Arthur J, Almeida JS. An XML standard for the dissemination of annotated 2D gel electrophoresis data complemented with mass spectrometry. BMC Bioinform 2004;5:9.
82. Ng SK, Tan SH. Discovering protein-protein interactions. J Bioinform Comput Biol 2004;1:711-741.
83. Taylor CF, Paton NW, Grawood KL, Kirby PD, Stead DA, Yin Z et al. A systematic approach to modelling, capturing, and disseminating proteomics experimental data. Nat Biotechnol 2003;21:247-254.
84. Mann M, Jensen ON. Proteomic analysis of post-translational modification. Nat Biotechnol 2003;21:255-261.
85. Hedges LV, Olkin I. Statistical methods for meta-analysis. New York: Academic Press, 1985.
86. Ermoaeva O, Rastogi M, Pruitt KD, Schuler GD, Bittner ML, Chen Y et al. Data management and analysis for gene expression arrays. Nat Genet 1998;20:19-23.
87. Crameri R, Blaser K. Allergy and immunity to fungal infections and colonization. Eur Respir J 2002;19:151-157.
88. Niggemann B, Breiteneder H. Latex allergy in children. Int Arch Allergy Immunol 2000;121:98-107.
89. Poulsen LK. In-vitro diagnosis: serum-based methods used for risk assessment of allergenic food. Curr Opin Allergy Clin Immunol 2001;1:249-254.
90. Brusic V, Millot M, Petrovsky N, Gendel SM, Gignozac O, Stelman SJ. Allergen databases. Allergy 2003;58:1093-1100.
91. Ferreira F, Hawranek T, Gruber P, Wopfner N, Mari A. Allergic cross-reactivity: from gene to the clinic. Allergy 2004;59:243-267.
92. Brusic V, Petrovsky N, Gendel SM, Millot M, Gigonzac O, Stelman SJ. Computational tools for the study of allergens. Allergy 2004;58:1083-1092.
93. Yu CJ, Lin YF, Chiang BL, Show LP. Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2. J Immunol 2003;170:445-453.
94. Fujimura T, Shigeta S, Kawamoto S, Aki T, Masubuchi M, Hayashi T et al. Two-dimensional IgE-binding spectrum of Japanese cedar (Cryptomeria japonica) pollen allergens. Int Arch Allergy Immunol 2004;133:125-135.
95. Haishima Y, Tsuchiya T, Tomitaka-Yagami A, Kano H, Matsunaga K. Proteomic analysis of putative latex allergens. Int Arch Allergy Immunol 2004;135:3-11.
96. Kolarich D, Altmann F. N-Glycan analysis by matrix-assisted laser desorption/ionization mass spectrometry of electrophoretically separated nonmammalian proteins: application to peanut allergen Ara h 1 and olive pollen Ole e 1. Anal Biochem 2000;285:64-75.
97. Raftery MJ, Saldanha RG, Geczy CL, Kumar RK. Mass spectrometric analysis of electrophoretically separated allergens and proteases in grass pollen diffusates. Respir Res 2003;4:10
98. Grönlund H, Bergman T, Sandstrom K, Alvelius G, Reininger R, Verdino P et al. Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem 2003;278:40144-40151.
99. Westphal S, Kolarich D, Foetisch K, Lauer I, Altmann F, Conti A et al. Molecular characterization and allergenic activity of Lyc e 2 (beta-fructofuranosidase), a glycosylated allergen of tomato. Eur J Biochem 2003;270:1327-1337.
100. Blume C, Lindner B, Pecker WM, Petersen A. Microheterogeneity of the major grass group 6 allergen Phl p 6: analysis by mass spectrometry. Proteomics 2004;4:1366-1371.
101. Rautiainen J, Auriola S, Konttinen A, Virtanen T, Rytkonen-Nissinen M, Zeiler T et al. Two new variants of the lipocalin allergen Bos d2. J Chromatogr B Biomed Sci Appl 2001;763:91-98.
102. Boggs SF. Protein profiling in respiratory disease: techniques and impact. Expert Rev Proteomics 2004;1:29-36.
103. Westergren-Thorsson G, Malmstrom J, Marko-Varga G. Proteomics - the protein expression technology to study connective tissue biology. J Pharm Biomed Anal 2001;24:815-824.
104. Malmstrom J, Tufvesson E, Lofdahl CG, Hansson L, Makro-Varga G, Westergren-Thorsson G. Activation of platlet-derivated growth factor pathway in human asthmatic pulmonary-derived mesenchymal cells. Electrophoresis 2003;24:276-285.
105. Fehniger TE, Sato-Folatre JG, Malmstron J, Berglund M, Lindberg C, Brange C et al. Exploring the context of the lung proteome within the airway mucosa following allergen challenge. J Proteome Res 2004;3:307-320.
106. Sepper R, Prikk K. Proteomics: is it an approach to understand the progression of chronic lung disorders? J Proteome Res 2004;3:277-281.
107. Houtman R, Krijgsveld J, Kool M, Romijn EP, Redegeld FA, Nijkamp FP et al. Lung proteome alterations in a mouse model for nonallergic asthma. Proteomics 2003;3:2008-2018.
108. Wheelock AM, Zhang L, Tran MU, Morin D, Penn S, Buckpitt AR et al. Isolation of rodent airway epithelial cell proteins facilitates in vivo proteomics studies of lung toxicity. Am J Physiol Lung Cell Mol Physiol 2004;286:399-410.
109. Crameri R, (editor). Peptidomics: a new dimension in functional genomics. Hot topics Issue, Combin Chem High Throughput Screen. 2005 (in press).
110. Svensson M, Skold K, Svenningsson P, Andren PE. Peptidomic-based discovery of neuropeptides. Proteome Res 2003;2:213-219.
111. Schrader M, Schulz-Knappe P. Peptidomics technologies for human body fluids. Trends Biotechnol 2001;19:S55-S60.
112. Tammen H, Möhring T, Kellmann M, Pich A, Kreipe HH, Hess R. Mass spectrometric phenotyping of Val34-Lue polymorphism of blood coagulation factor XIII by differential peptide display. Clin Chem 2004;50:545-551.
113. Tammen H, Kreipe H, Hess R, Kellmann M, Lehmann U, Pich A et al. Expression profiling of breast cancer cells by differential peptide display. Breast Cancer Res Treat 2003;79:83-93.
114. Sasaki K, Sato K, Akiyama Y, Yanagihara K, Oka M, Yamaguchi K. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res 2002;62:4894-4898.
115. Pierson J, Norris JL, Aerni HR, Svenningsson P, Caprioli RM, Andren PE. Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J Proteome Res 2004;3:289-295.
116. Budde P, Schulte I, Appelt A, Kellmann M, Neitt S, Hess R et al. Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes. Combin Chem High Throughput Screen (in press).
117. de Jong A. Contribution of mass spectrometry to contemporary immunology. Mass Spectrom Rev 1998;17:311-335.
118. Dowuuard KM. Contributions of mass spectrometry to structural immunology. J Mass Spectrom 2000;35:493-503.
119. Halapi E, Hakonarson H. Recent development in genomic and proteomic research for asthma. Curr Opin Pulm Med 2004;10:22-30.
120. Yeo S, Roh GS, Kim DH, Lee JM, Seo SW, Cho JW et al. Quantitative profiling of plasma peptides in asthmatic mice using liquid chromatography and mass spectrometry. Proteomics 2004;4:3308-3317.
121. Gires O, Munz M, Schaffrik M, Kieu C, Rauch J, Abelmann M et al. Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology. Cell Mol Life Sci 2004;61:1198-1207.
122. Malmstrom J, Tufvesson E, Lofdahl CG, Hansson L, Marko-Varga G, Westergren-Thorsson G. Activation of platelet-derived growth factor pathway in human asthmatic pulmonary-derived mesenchymal cells. Electrophoresis 2003;24:276-285.
123. Lamerz J. Peptides and peptide networks in human cerebrospinal fluid. PhD Thesis No 15623, Switzerland: Swiss Federal Institute of Technology, Zürich, 2004.
124. Schulz-Knappe P, Budde P, Jürgens M, Schrader M, Selle H, Tammen H et al. Biomarker- und Wirkstoffsuche von Peptiden und kleinen Proteinen. Laborwelt 2004;5:40-45.
125. Englbrecht CC, Facius A. Bioinformatics challenges in proteomics. Combin Chem High Throughput Screen 2005 (in press).
126. Washburn MP, Wolters D, Yates JR. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001;25:242-247.